B. Metzler Seel. Sohn & Co. Holding Ag Seagen Inc. Transaction History

B. Metzler Seel. Sohn & Co. Holding Ag

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	N/A	-8,094 Closed	0 $0
Q3 2021 Nov 01, 2021	SELL	$142.45 - $169.82 $23,646 - $28,190	-166 Reduced 2.01%	8,094 $1.37 Million
Q2 2021 Aug 30, 2021	BUY	$135.08 - $161.1 $514,654 - $613,791	3,810 Added 85.62%	8,260 $1.3 Million
Q1 2021 May 20, 2021	BUY	$137.51 - $190.8 $137,372 - $190,609	999 Added 28.95%	4,450 $618,000
Q4 2020 Mar 08, 2021	BUY	$164.63 - $211.93 $568,138 - $731,370	3,451 New	3,451 $634,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of B. Metzler Seel. Sohn & Co. Holding Ag, based on Form 13F filings with the SEC.

Stay updated on B. Metzler Seel. Sohn & Co. Holding Ag with notifications on news.